Trial Profile
The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Foveal Involving Edema and Lipid Exudates
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Jul 2021
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 26 Sep 2019 Status changed from active, no longer recruiting to completed.
- 17 Apr 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Jun 2018.
- 17 Apr 2018 Status changed from recruiting to active, no longer recruiting.